×

Become an Incathlab member and receive full access to its content!

You must be an Incathlab member to access videos without any restrictions. Register for free in one minute and access all services provided by Incathlab.You will also be able to log into Incathlab from your Facebook or twitter account by clicking on login on the top-right corner of Incathlab website.

Registration Login


Chapters (5)
Description
Date : May 2017
Honolulu : Wednesday, May 24th 2017 from 12:30am to 02am (GMT-10)
San Francisco : Wednesday, May 24th 2017 from 03:30am to 05am (GMT-7)
New York : Wednesday, May 24th 2017 from 06:30am to 08am (GMT-4)
Buenos Aires : Wednesday, May 24th 2017 from 07:30am to 09am (GMT-3)
Reykjavik : Wednesday, May 24th 2017 from 10:30am to 12pm (GMT)
London / Dublin : Wednesday, May 24th 2017 from 11:30am to 01pm (GMT+1)
Paris / Berlin : Wednesday, May 24th 2017 from 12:30pm to 02pm (GMT+2)
Istanbul : Wednesday, May 24th 2017 from 01:30pm to 03pm (GMT+3)
Moscou / Dubaï : Wednesday, May 24th 2017 from 02:30pm to 04pm (GMT+4)
Bangkok : Wednesday, May 24th 2017 from 05:30pm to 07pm (GMT+7)
Shanghai : Wednesday, May 24th 2017 from 06:30pm to 08pm (GMT+8)
Tokyo : Wednesday, May 24th 2017 from 07:30pm to 09pm (GMT+9)
Sydney : Wednesday, May 24th 2017 from 09:30pm to 11pm (GMT+11)
Wellington : Wednesday, May 24th 2017 from 11:30pm to 01am (GMT+13)
Last update : 2017-06-22
Language(s) : English

The benefits of lower-profile devices are obvious. Not only can more patients with smaller access vessels be treated without the need ...

The benefits of lower-profile devices are obvious. Not only can more patients with smaller access vessels be treated without the need for conduit access or bypass graft surgery, but access site complications are lower the smaller the device, and more can be done percutaneously without the need for surgical arteriotomy for access.
Discover in this webinar the ultra-low profile abdominal aortic aneurysm stent graft system, which demonstrated to be easy to use, accurate in placement and effective in navigational challenges.

Program

12:30 Product Review & 5 years Innovation study results - Dr Llaneza
12:45 1st Case "Narrow access case" - Panel Discussion
Dr Llaneza, Dr del Castro and Dr Alonso
13:15 Incraft® Concept: an advantage ONLY for complex access? - Dr del Castro
           Preserve Hypogastric - IN Situ Sizing
           Short Necks - Deployment accuracy
13:25 2nd Case"Hypogastric preservation case" - Panel Discussion
Dr Llaneza, Dr del Castro and Dr Alonso
13:55 Closing & Remarks

 

Educational objectives

  • Discuss current use of ultra-low profile Incraft® AAA stent graft systems
  • Learn from expert discussion of the patients’ outcomes with low profile Incraft® AAA  stent graft system treatment 
  • Demonstrate advanced techniques in the treatment of aortic disease
  • Demonstrate new tools available
  • Provide platform for discussion and mutual learning

​Bibliography

Audience

  • Endovascular specialists (Vascular Surgeons, Interventional Radiologists, Interventional Angiologists and Interventional Cardiologists)
  • Referring physicians of patients with vascular disease
     
IMPORTANT NOTICE
 
This webinar is an educational event supported by Cordis Corporation, and is intended for Healthcare Professionals in Europe Middle East and Africa. 
The use of the INCRAFT® AAA Stent-Graft System requires that physicians be specially trained in endovascular abdominal aortic aneurysm repair techniques, including experience with high resolution fluoroscopy and radiation safety. Cordis Corporation will provide training specific to the INCRAFT® AAA Stent-Graft System.
The INCRAFT® System is currently approved for investigational device use only in the U.S. and Japan and is being studied in a global pivotal clinical study in the U.S. and Japan called the INSPIRATION Trial, which completed enrollment in 2013.
 
While every effort is made to see that no inaccurate or misleading data, opinions, or statements appear in this webinar, Cordis Corporation wish to make it clear that material contained in the webinar represents independent evaluations and opinions of the authors and contributors. As a consequence, Cordis Corporation accepts no responsibility for the consequences of any such inaccurate or misleading data or statements. Neither do they endorse the content or the use of any drug or medical device in a way that lies outside its current licensed application in any territory. This presentation may include the demonstration of the use of medical devices; it is not intended to be used as a training guide. The steps demonstrated may not be the complete steps of the procedure. Individual preference and experience, as well as patient needs, may dictate variation in procedure steps. Before using any medical device, including those demonstrated or referenced in this webinar, review all relevant package inserts, with particular attention to the indications, contraindications, warnings and precautions, and steps for use of the device.
 
All content in these presentations is owned by their authors and is protected by worldwide copyright laws. No modification or further reproduction of the content is permitted. 
Dr Manuel Alonso,  Dr Llaneza and Dr  Del Castro  are  compensated by and presenting on behalf of Cordis. 
 
For Healthcare Professionals Only. 
©2017 Cardinal Health. 
Cordis, Cordis LOGO and INCRAFT are trademarks or registered trademarks of Cardinal Health.
 
EU2321 05/17
Linked playlists (5)
Comments(4)
Join the Discussion
  • Martin R. Thanks for your presentation. Do you believe an RCT is needed to demonstrate benefits of PEVAR vs opening the groin?

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Enrique P. the overlapping zone...should be the same in both limbs ??

      • José Antonio D. Sorry for not answering your question in the live session. Overlapping can be adjusted independently in each limb. The ipsilateral limb is approximately 1cm longer than the contralateral limb. From the end of each limb there is a 2 cm minimum overlapping for both, and other 3 cm proximally in the ipsilateral limb (5 cm total) / 2 cm contralateral (4 cm total), with which you can "play" and adjust the length as necessary.

        Un abrazo desde Oviedo.

      Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
      Your browser doesn't have Flash, Silverlight or HTML5 support.


    • Alexandre Coutinho . Thank you to share the cases. Best regards

        Please, select your files, click upload button, write your comment and click the send button. (allowed formats : images jpeg, gif, png, and PDF)
        Your browser doesn't have Flash, Silverlight or HTML5 support.


      Comment with Facebook

      September 2015
      Honolulu : Thursday, September 24th 2015 from 05am to 06am (GMT-10)
      San Francisco : Thursday, September 24th 2015 from 08am to 09am (GMT-7)
      New York : Thursday, September 24th 2015 from 11am to 12pm (GMT-4)
      Buenos Aires : Thursday, September 24th 2015 from 12pm to 01pm (GMT-3)
      Reykjavik : Thursday, September 24th 2015 from 03pm to 04pm (GMT)
      London / Dublin : Thursday, September 24th 2015 from 04pm to 05pm (GMT+1)
      Paris / Berlin : Thursday, September 24th 2015 from 05pm to 06pm (GMT+2)
      Istanbul : Thursday, September 24th 2015 from 06pm to 07pm (GMT+3)
      Moscou / Dubaï : Thursday, September 24th 2015 from 07pm to 08pm (GMT+4)
      Bangkok : Thursday, September 24th 2015 from 10pm to 11pm (GMT+7)
      Shanghai : Thursday, September 24th 2015 from 11pm to 12am (GMT+8)
      Tokyo : Friday, September 25th 2015 from 12am to 01am (GMT+9)
      Sydney : Friday, September 25th 2015 from 02am to 03am (GMT+11)
      Wellington : Friday, September 25th 2015 from 04am to 05am (GMT+13)

      Complex femoro-popliteal interventions

      What are the limits?

      Share
      October 2014
      Honolulu : Tuesday, October 28th 2014 from 04am to 06am (GMT-10)
      San Francisco : Tuesday, October 28th 2014 from 06am to 08am (GMT-8)
      New York : Tuesday, October 28th 2014 from 09am to 11am (GMT-5)
      Buenos Aires : Tuesday, October 28th 2014 from 11am to 01pm (GMT-3)
      London / Dublin : Tuesday, October 28th 2014 from 02pm to 04pm (GMT)
      Paris / Berlin : Tuesday, October 28th 2014 from 03pm to 05pm (GMT+1)
      Istanbul : Tuesday, October 28th 2014 from 04pm to 06pm (GMT+2)
      Moscou / Dubaï : Tuesday, October 28th 2014 from 06pm to 08pm (GMT+4)
      Bangkok : Tuesday, October 28th 2014 from 09pm to 11pm (GMT+7)
      Shanghai : Tuesday, October 28th 2014 from 10pm to 12am (GMT+8)
      Tokyo : Tuesday, October 28th 2014 from 11pm to 01am (GMT+9)
      Sydney : Wednesday, October 29th 2014 from 12am to 02am (GMT+10)
      Wellington : Wednesday, October 29th 2014 from 02am to 04am (GMT+12)

      Current indications for SFA stenting

      Live cases from Münster (Germany)

      Share
      March 2017
      Honolulu : Friday, March 24th 2017 from 12:30am to 01:30am (GMT-10)
      San Francisco : Friday, March 24th 2017 from 02:30am to 03:30am (GMT-8)
      New York : Friday, March 24th 2017 from 05:30am to 06:30am (GMT-5)
      Buenos Aires : Friday, March 24th 2017 from 07:30am to 08:30am (GMT-3)
      London / Dublin : Friday, March 24th 2017 from 10:30am to 11:30am (GMT)
      Paris / Berlin : Friday, March 24th 2017 from 11:30am to 12:30pm (GMT+1)
      Istanbul : Friday, March 24th 2017 from 12:30pm to 01:30pm (GMT+2)
      Moscou / Dubaï : Friday, March 24th 2017 from 02:30pm to 03:30pm (GMT+4)
      Bangkok : Friday, March 24th 2017 from 05:30pm to 06:30pm (GMT+7)
      Shanghai : Friday, March 24th 2017 from 06:30pm to 07:30pm (GMT+8)
      Tokyo : Friday, March 24th 2017 from 07:30pm to 08:30pm (GMT+9)
      Sydney : Friday, March 24th 2017 from 08:30pm to 09:30pm (GMT+10)
      Wellington : Friday, March 24th 2017 from 10:30pm to 11:30pm (GMT+12)

      New evidence for new generation stents

      in Femoro-popliteal and BTK occlusions

      Share
      January 2015
      Honolulu : Friday, January 16th 2015 from 02:45am to 03:30am (GMT-10)
      San Francisco : Friday, January 16th 2015 from 04:45am to 05:30am (GMT-8)
      New York : Friday, January 16th 2015 from 07:45am to 08:30am (GMT-5)
      Buenos Aires : Friday, January 16th 2015 from 09:45am to 10:30am (GMT-3)
      London / Dublin : Friday, January 16th 2015 from 12:45pm to 01:30pm (GMT)
      Paris / Berlin : Friday, January 16th 2015 from 01:45pm to 02:30pm (GMT+1)
      Istanbul : Friday, January 16th 2015 from 02:45pm to 03:30pm (GMT+2)
      Moscou / Dubaï : Friday, January 16th 2015 from 04:45pm to 05:30pm (GMT+4)
      Bangkok : Friday, January 16th 2015 from 07:45pm to 08:30pm (GMT+7)
      Shanghai : Friday, January 16th 2015 from 08:45pm to 09:30pm (GMT+8)
      Tokyo : Friday, January 16th 2015 from 09:45pm to 10:30pm (GMT+9)
      Sydney : Friday, January 16th 2015 from 10:45pm to 11:30pm (GMT+10)
      Wellington : Saturday, January 17th 2015 from 12:45am to 01:30am (GMT+12)

      Vascular Mimetic Technology : SUPERA - SUPERB

      Share
      Scroll Up